China A-share innovative-drug names rebounded intraday after earlier swings.
Dezhan Health hit the daily limit-up in two of the past three sessions; Haooubo
gained about 10%. Qianjin Pharmaceutical, Wanbang Pharma, Borui Medical and
Harbin Pharmaceutical also advanced.